Genus Lifesciences Revenue and Competitors

Allentown, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Genus Lifesciences's estimated annual revenue is currently $15.5M per year.(i)
  • Genus Lifesciences's estimated revenue per employee is $201,000

Employee Data

  • Genus Lifesciences has 77 Employees.(i)
  • Genus Lifesciences grew their employee count by 3% last year.

Genus Lifesciences's People

NameTitleEmail/Phone
1
VP Quality AssuranceReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Director Regulatory Affairs -GenericsReveal Email/Phone
4
Associate Director Product DevelopmentReveal Email/Phone
5
Associate Director Quality ControlReveal Email/Phone
6
Director IT/ISReveal Email/Phone
7
Manager - Analytical R&DReveal Email/Phone
8
Engineering ManagerReveal Email/Phone
9
Associate ManagerReveal Email/Phone
10
Stability ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Genus Lifesciences?

Genus Lifesciencesâ„¢ Genus Lifesciencesâ„¢ is a specialty pharmaceutical company engaged in the development and commercialization of generic and branded pharmaceutical products. Founded in 1999, Genus Lifesciencesâ„¢ employs over one hundred professionals in all phases of pharmaceutical operations; and its products are available in pharmacies and other retail outlets throughout the United States. In addition to its local presence, Genus Lifesciencesâ„¢ has on-going research efforts through global partnerships related to its technology platforms.

keywords:N/A

N/A

Total Funding

77

Number of Employees

$15.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.2M777%N/A
#2
$22.3M770%N/A
#3
$19.6M7842%N/A
#4
$19.7M807%N/A
#5
$19.6M805%N/A